NCT07004569View on ClinicalTrials.gov

Angiolite Registry Study

RecruitingOBSERVATIONAL
Enrollment

55

Participants

Timeline

Start Date

May 28, 2024

Primary Completion Date

May 30, 2025

Study Completion Date

July 28, 2025

Conditions
With Left Main Coronary Artery Lesions
Interventions
DEVICE

Percutaneous coronary intervention (PCI)

Patients is under Percutaneous coronary intervention (PCI) by using contemporary drug eluting stent (DES). Angiolite is a thin-strut cobalt-chromium durable fluoroacrylate polymer-based, sirolimus-eluting stent that is CE marked and commercially available. Stent sizes 2.0mm to 4.5mm in 9mm to 49mm lengths will be used.

Trial Locations (1)

0000

RECRUITING

Prince of Wales Hospital, Hong Kong

All Listed Sponsors
lead

Chinese University of Hong Kong

OTHER